News Digest
Expert Commentary

FACULTY SPOTLIGHT

CMHC Annual 2021 Lipid Management Panel

Christie Ballantyne,
MD

Robert Eckel,
MD

Matthew Budoff,
MD

CMHC Chairs Christie Ballantyne, MD and Robert Eckel, MD, as well as CMHC faculty Matthew Budoff, MD recap the lipid sessions presented at the 16th Annual CMHC, including perspectives and clinical pearls on ASCVD risk assessment, residual ASCVD risk, and ASCVD management and prevention.

Interview #1

Lipid Management in Very High-Risk Patients Post-MI: Expert Perspectives with Drs. Taub, Desai, Shapiro

Pam Taub,
MD, FACC
Nihar R. Desai,
MD, MPH, FACC
Michael D. Shapiro,
DO, MCR, FACC, FAHA

Watch Drs. Taub, Desai, and Shapiro discuss some additional perspectives on the management of very high-risk, including:

  • The safety of very low LDL-C
  • Concerns with statins and new-onset diabetes and how to address overall patient concerns about lipid-lowering therapy
  • Residual ASCVD risk beyond LDL-C
Additional Resources